Chantal Visser

15PUBLICATIONS
70CO-AUTHORS
Nanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological modellingCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 02, 2026
Anticoagulation Therapeutic Ranges and Clinical Outcomes in Patients with a Mechanical Heart Valve Treated with Vitamin K Antagonists-a Nationwide Linked-data Dutch Study.

Chantal Visser, Eva K Kempers, Jaap Seelig

|Sep 01, 2025
Anti-thrombotic therapy in patients with cancer at the end of life: A cohort study using population-linked routinely collected data.

Sarah J Aldridge, Ashley Akbari, Adrian Edwards

|May 20, 2025
Quality of vitamin K antagonist treatment during the last year of life.

Chantal Visser, Eva K Kempers, Jamilla Goedgebuur

|Apr 02, 2025
Incidence, risk factors, and mortality of pulmonary embolism in the Netherlands (2015-22): sex differences and shifts during the coronavirus disease 2019 pandemic.

Qingui Chen, Nienke van Rein, Luuk J J Scheres

|Jan 24, 2025
Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-Limiting Disease.

Eva K Kempers, Chantal Visser, Eric C T Geijteman

|Dec 23, 2023
Transient Autoreactive PF4 and Antiphospholipid Antibodies in COVID-19 Vaccine Recipients.

Matthijs P Raadsen, Chantal Visser, A H Ayesha Lavell

Pageof 3

Frequent Collaborators

10 joint publications

Marieke J H Kruip

6 joint publications

Eva Kempers

5 joint publications

Frederikus A Klok

4 joint publications

Suzanne Cannegieter